



Congenital Heart Disease Choi et alMyocyte apoptosis occurs early during the development of
pressure-overload hypertrophy in infant myocardium
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Objective: Abnormal hemodynamic loading often accompanies congenital heart disease both before and after
surgical repair. Adaptive and maladaptive myocardial responses to increased load are numerous. This study ex-
amined the hypothesis that myocyte loss occurs during compensatory hypertrophic growth in the developing
infant myocardium subjected to progressive pressure overload.
Methods: Pressure-overload left ventricular hypertrophy was induced in 7- to 10-day-old rabbits by banding the
thoracic aorta. Left ventricular function and mechanics were quantified by serial echocardiography and noninva-
sive left ventricular wall stress analysis. Left ventricular tissue sections were examined for fibrosis by using Mas-
son’s trichrome stain and for myocyte apoptosis by using a myocyte-specific DNA fragmentation assay and
caspase-3 activation (specific fluorescent substrate).
Results: Significant myocyte apoptosis (198  37/106 myocytes, P< .01 vs control) and caspase-3 activation
were present in early hypertrophy when left ventricular contractility was preserved and compensatory hypertro-
phy had normalized wall stress. By 6 weeks, multiple indices of left ventricular contractility were reduced, and left
ventricular wall stress was increased. Myocyte apoptosis was accelerated (361  56/106 myocytes), caspase-3
activity further increased, and the estimated total number of left ventricular myocytes was significantly reduced
by 18%  4%.
Conclusion: In experimental infant left ventricular hypertrophy, myocyte apoptosis is initiated in the face of nor-
malized wall stress and preserved contractility. The ongoing rate of apoptosis causes a measurable decrease in
myocyte number that is coincident with the onset of ventricular dysfunction. It thus appears that pressure over-
load, even at its earliest stages, is not well tolerated by the developing ventricle.Supplemental material is available online.
Congenital heart disease is commonly associated with ab-
normal hemodynamic loading (pressure or volume). Be-
cause complete structural and hemodynamic correction is
frequently impossible, abnormal loading is a persistent prob-
lem in many patients. In the setting of sustained pressure
overload, ventricular adaptation typically progresses
through stages that include compensatory hypertrophy
caused by the parallel addition of sarcomeres, which results
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According to LaPlace’s Law, myocardial wall stress can
be calculated from the formula (pressure 3 radius)/(2 3
wall thickness), and thus an increase in wall thickness can
ameliorate increased wall stress caused by an increase in
pressure. Because ventricular ejection is directly affected
by afterload, it is believed that normalization of systolic
stress (afterload) via increasing wall thickness is an impor-
tant mechanism to maintain systolic performance in the
face of increased systolic pressure. Failure to do so results
in afterload mismatch where the degree of hypertrophy
can no longer compensate for increased afterload.1,2
Numerous changes in gene expression and protein synthe-
sis accompany this response. They include alterations in sar-
comeric protein isoforms and activity; calcium handling and
regulatory proteins (eg, the sarcoplasmic reticular Ca-AT-
Pase, SERCA-2); substrate and energy metabolism; adrener-
gic,muscarinic, and angiotensin receptor species and activity;
growth factor and cytokine production; and stimulation of
other pleiotropic signaling pathways, such as calcineurin.2-8
Abnormalities in parameters such as extracellular matrix sig-
naling, matrix turnover, coronary blood supply, and angio-
genesis have also been described and implicated in both the
compensatory and pathologic hypertrophic responses.
The specific molecular mechanisms underlying the failure
of continued hypertrophic compensation and the progres-
sion of contractile dysfunction are not well understood,rgery c June 2009




ESS ¼ end-systolic stress
FS ¼ fiberstress
LV ¼ left ventricular
mw ¼ midwall
SF ¼ shortening fraction
SSI ¼ stress shortening index
SVI ¼ stress velocity index
TUNEL ¼ terminal deoxynucleotide
transferase-mediated dUTP nick-end
labeling
VCFc ¼ rate of circumferential fiber shortening
especially in the immature, developing ventricle. Myocyte
apoptosis has been implicated in numerous states associated
with reduced myocardial performance, including acute and
chronic ischemia, diabetes, myocarditis, Adriamycin toxic-
ity, hypertrophy, and heart failure.8-19 Although the data
showing that apoptosis occurs in these settings are signifi-
cant, their functional importance remains unclear, particu-
larly with regard to the adaptation to chronic pressure
load. Several studies have quantified cardiomyocyte apopto-
sis in late-stage chronic hypertrophy of adult myocar-
dium,20,21 but there is no evidence of this process in the
developing heart. Cell growth, survival, and death signaling
pathways are different than in the adult in both the normal
developing myocardium and that exposed to pressure over-
load. We therefore examined the hypothesis that hypertro-
phic growth would stimulate myocyte apoptosis in the




The institutional animal care and use committee approved these experi-
ments. New Zealand white rabbits (aged 7–10 days) were used to create
a model of progressive left ventricular (LV) hypertrophy. After anesthesia
was induced with intramuscular ketamine (20 mg/kg) and xylazine (0.5
mg/kg), a left thoracotomy was performed under sterile conditions. A
2-0 silk suture was placed around the descending aorta just distal to the lig-
amentum arteriosum, with care taken to make the suture as snug as possible
without acutely causing stenosis of the descending aorta. After chest clo-
sure, air was evacuated from the left thoracic cavity by catheter aspiration.
After recovery from anesthesia, animals were returned to their mothers and
allowed to feed in the normal manner. With growth, an aortic coarctation
gradually develops. In preparation for later evaluations, weekly shaving
of the right upper limb and thorax, as well as sham echocardiograms,
were performed to accustom the animals to the procedure and reduce the
stress response to actual echocardiography, thus avoiding the need for anes-
thesia or sedation during serial echocardiographic examinations.
For controls, age- and litter-matched New Zealand white rabbits were
sham-operated and otherwise handled identically. Echocardiography and
noninvasive blood pressure determination were performed at weekly inter-
vals in the banded and age-matched control animals (see Appendix). A sep-
arate group of normal animals was used to determine the normal relationshipThe Journal of Thoracic and Cin the rabbit of shortening fraction (SF) to afterload (end-systolic stress
[ESS]) (stress shortening index [SSI]), rate of circumferential fiber shorten-
ing to ESS (afterload) (VCFc to ESS; stress velocity index [SVI]), and their
midwall equivalents (SFmw and VCFcmw) compared with fiberstress (FS) to
determine SSImw and SVImw. Blood pressure was determined serially and
noninvasively using optical plethysmography (Finapress, Ohmeda, Engle-
wood, Colo). The Finapress was applied to the shaved right forearm after
application of topical alcohol over the region of the palpable brachial artery.
The accuracy of the Finapress versus direct central arterial cannulation (ca-
rotid artery) to measure arterial blood pressure and calculate load-adjusted
echocardiographic indices was validated in a separate set of experiments
(see Appendix for details).
Histochemical Methods
Animals were sacrificed at weekly intervals, and hearts were immedi-
ately perfusion fixed in 4% paraformaldehyde in phosphate-buffered saline,
pH 7.4, and paraffin embedded and sectioned. Mid-LV myocardial sections
were deparaffinized, hydrated in a descending alcohol series, and boiled 3
times for 5 minutes in 1 mmol/L EDTA pH 8.0 (antigen retrieval) before
staining. Slides were imaged on a Zeiss Axiovert microscope (Carl Zeiss
MicroImaging, Inc., Thornwood, NY) equipped with visible/ultraviolet/
fluorescent objectives (4–1003), xenon light source/Sutter filter wheel
(Sutter Instrument Company, Novato, Calif), and appropriate excitation/
emission filter sets. Images were recorded using a Princeton Instruments
cooled CCD camera (Princeton Instruments, Trenton, NJ) or Leica digital
color camera (Leica Microsystems Inc., Bannockburn, Ill), depending on
the probe type; images were stored and analyzed using MetaMorph and
MetaFluor software (Molecular Devices, Sunnyvale, Calif).
Quantification of Apoptosis
Terminal deoxynucleotide transferase-mediated dUTP nick-end labeling
(TUNEL) staining of DNA stand breaks was done with enhanced fluores-
cent detection by labeling cleaved double-stranded DNA in tissue sections
following the Fluorescein FragEL detection kit (Oncogene, Boston, Mass).
Positive and negative controls of this assay were previously performed in in
vitro cell culture models using rabbit thoracic lymph nodes (data not
shown). For DNA staining of nuclei, 10 mg/mL Hoechst 33258 in phos-
phate-buffered saline/50% glycerol was used. Myocytes were identified
by co-staining with mouse anti-desmin monoclonal antibody (Sigma, St
Louis, Mo) at a dilution of 1:100 in phosphate-buffered saline containing
5% horse serum and detected with Alexa 568 goat anti-mouse secondary
antibody (Molecular Probes, Eugene, Ore). By using MetaMorph software,
the following parameters were quantified: 1) total nuclei (Hoechst-positive),
2) total myocyte nuclei (Hoechst-positive in desmin-positive cells), and 3)
number of TUNEL-positive myocyte nuclei (TUNELþ/Hoechstþ/desminþ).
For maximum specificity, a ‘‘positive’’ result (ie, apoptotic cardiomyocyte)
was counted only when a TUNEL-positive signal (green) was co-localized
to nuclear DNA (blue) that was located within a cardiomyocyte (red).
Activation of caspase-3 was used as another index of proapoptotic signal-
ing. Total LV protein was extracted by homogenizing 20 to 30 mg of LV
myocardium in 4C lysis buffer A (consisting of 25 mmol/L HEPES
[pH 7.5], 10 mmol/L KCl, 1.5 mmol/L MgCl2, 1 mmol/L ethylenediamine
tetraacetic acid, 1 mmol/L ethylene glycol bis aminoethyl ether tetra-acetic
acid, 1 mmol/L benzamidine, 1 mmol/L dithiothreitol, and 1 mmol/L
phenylmethylsulfonyl fluoride) containing 1% [v/v] Triton X-100). After
centrifugation at 100,000g for 60 minutes at 4C, supernatant protein con-
centrations were determined using the Bradford method according to the
manufacturer’s instructions (BioRad, Hercules, Calif). Protein extract (25
mg) and 25mL reaction buffer (0.1mol/LHEPESpH7.0, 10% polyethylene
glycol, 0.1% cholamidopropyl dimethylammonio propanesulfonate, 10
mmol/L dithiothreitol) were mixed with 1 mL of 5 mmol/L fluorogenic
caspase-3–specific substrate (DEVD-AFC; BioMol, Plymouth Meeting,
Pa). After incubation at 37C for 2 hours in 96-well fluorescence-specific
plates, fluorescence was quantified in a microplate reader (Perkin Elmer,ardiovascular Surgery c Volume 137, Number 6 1357
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DBoston, Mass) at excitation and emission wavelengths of 400 and 505 nm,
respectively.22 Relative caspase-3 activity was expressed as fold change rel-
ative to that found in LV from 8-week-old sham-operated animals.
Assessment of Fibrosis
Tissue sectionswere prepared as above, stainedwithMasson’s trichrome,
and imaged using light microscopy. Images were collected with a Leica dig-
ital color CCD-camera. Total image area and the relative percentage of col-
lagen (blue) and tissue (red) were quantified using MetaMorph software.
Estimation of Myocyte Number
The total number of myocytes in the LV free wall of 7-week-old banded
and sham-operated animals was estimated as described by Kajstura and col-
leagues.14 Briefly, this requires enzymatically dissociated for estimation of
the frequency ofmono-, bi-, andmultinucleated myocytes (Hoechst staining)
and confocalmicroscopic estimation of the cell volume of thesemyocyte pop-
ulations by staining with FITC and propidium iodide (to label nuclei); cell
area was computed and thickness was measured by optical sectioning in
the Z plane. Next, the total ventricular volume was calculated as the weight
of LV free wall myocardium per 1.06 g/mL, the specific gravity ofmuscle tis-
sue. This was corrected for the percentage of replacement fibrosis (Masson’s
trichrome) to yield the volume of viable tissue, which was then used with the
estimation of the volume fraction of myocytes in the viable tissue to yield the
absolute volume of myocytes in the LV free wall. Next, the volume percent-
age of mono-, bi-, and multinucleated myocytes in the tissue was calculated,
which in combination with the absolute volume of myocytes in the tissue
allowed estimation of the aggregate volume of the different myocyte popula-
tions, and from this the number ofmyocytes in each populationwas estimated
and summed to yield the total number of myocytes in the ventricle.
Statistics
All results are expressed as mean  1 standard deviation unless other-
wise stated. To adjust for age- and growth-related changes in ventricular me-
chanics, echocardiographic variables were expressed as Z-scores (normal
deviates) relative to the distribution of each variable in the control animals.
Comparison of groups over time was performed using 2-way analysis of
variance (group and time) with repeated measures for time. Subsequent in-
tergroup testing used Scheffe’s method for post hoc pairwise comparisons.
Fold changes in caspase-3 activity between banded and age-matched sham
controls were compared using the Wilcoxon rank-sum procedure. Compar-
ison with the normal population (using Z-scores) was performed using a uni-
variate t test. Statistical analysis was performed on commercially available
software (SAS Proc Mixed, SAS Institute Inc, Cary, NC).
RESULTS
Control Echocardiographic Data
Thirteen normal rabbits were assessed serially from age 3 to
6 weeks during which time there was an approximate 4-fold
increase in bodymass. Heart rate, SF, VCFc, SFmw, VCFcmw,
mass:volume ratio, systolic blood pressure, end-systolic and
peak systolic stress, and end-systolic and peak FS were found
to have no significant change over time. The progressive in-
crease in LV end-diastolic dimension, posterior wall thick-
ness, and body weight reflects the rapid growth seen in these
animals in the first 7weeks of life.Values fromnormal animals
were used for comparison of banded animals with normal,
aged-matched controls, as well as to describe the normal
growth-related evolution of these variables. By using themea-
sures of ESS obtained during afterload manipulation, the nor-
mative data for the VCFc-ESS (SVI), SFmw-FSmw (SSImw),1358 The Journal of Thoracic and Cardiovascular Suand VCFcmw-FSmw (SVImw) relationships were determined.
Table 1 summarizes these data over time.
Serial Ventricular Mechanics after Aortic Banding
No significant alteration in SF was noted at the time of
aortic banding. The rate of increase in body weight was
not different from that of controls. Detailed serial myocar-
dial mechanics were available in 36 rabbits from weeks 3
to 7 and are summarized in Table 1. The earliest detected
change was an increase in LV mass:volume ratio (Figure 1),
which was associated with a significant decrease in peak sys-
tolic stress compared with age-matched controls (Figure 2)
by week 4. Thereafter, mass:volume ratio progressively de-
creased, resulting in elevated peak systolic stress and reflect-
ing a failure of adequate hypertrophy (Figures 1 and 2).
Cardiac performance, as measured by SF and VCFc, de-
clined progressively over time, reaching significantly lower
levels by weeks 6 and 7. Similar patterns were seen with
SFmw and VCFcmw reaching significantly lower levels by
week 5. Myocyte contractility, as quantified by the SSI
and SVI relationships, although initially sustained in the
normal range, decreased at week 6 (Table 1). The use of mid-
wall indices of contractility, which avoids the overestima-
tion of cardiac performance seen with endocardial indices
in hypertrophied myocardium, revealed significant changes.
SVImw and SSImw decreased significantly by week 5 and
continued to decline at 6 and 7 weeks. These serial changes
reflect an initial period of adequate hypertrophy and later on-
set of inadequate hypertrophy and depression in myocardial
contractility with concomitant chamber dilation.
Cardiomyocyte Apoptosis
Representative myocardial tissue sections with labeled nu-
clei (Hoechst-blue), myocytes (desmin-red), and nuclei un-
dergoing DNA fragmentation (TUNEL-green) are shown in
Figure 3, A. Quantification of TUNEL-positive cardiomyo-
cytes in thismodel is shown in Figure 3,B. The baseline num-
ber of TUNEL-positive nuclei ranged from 26 to 48 per
million cardiomyocytes and did not change in the sham-oper-
ated animals.Most interestingly, a significant increase in my-
ocyte apoptosis was apparent as early as 2 weeks after aortic
banding (3–4 weeks of age); this was occurring at a time
when LV mass was increasing, LV wall stress had normal-
ized, and contractility was preserved (compare with Figures
1 and 2 andTable 1). Therewas a similar increase inLV tissue
caspase-3 activity at this early time point (Figure 4). The rate
of myocyte apoptosis as indicated by TUNEL and activation
of caspase-3 in the LV continued to increase, in association
with inadequate hypertrophic compensation, increasing
wall stress, decreasing contractility, and chamber dilatation.
Left Ventricular Myocyte Number and Fibrosis
There were no measurable differences in LV myocyte
numbers within the sham-operated group; myocyte volumergery c June 2009
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DTABLE 1. Echocardiographic parameters in control and banded animals
Week 3 Week 4 Week 5 Week 6 Week 7
Variable Control Banded Control Banded Control Banded Control Banded Control Banded
SSI (Z-score) 0.2  1.2 0.1  1.1 0.1  0.9 0.1  0.9 0.4  0.8 0.1  1.7 0.8  1.1 1.0  2.0 0.7  0.9 1.6  1.9a
SSImw (Z-score) 0.1  0.8 0.6  1.3 0.2  0.9 0.6  1.0 0.9  0.9 0.8  1.3a 0.8  1.1 1.3  1.6a 1.1  1.2 1.4  1.0a
SVI (Z-score) 0.2  1.1 0.4  0.2 0.4  0.8 0.6  0.6 0.4  0.6 1.2  0.2a 0.6  1.2 1.6  0.4a 0.6  0.9 1.7  0.5a
SVImw (Z-score) 0.2  0.7 0.2  1.7 0.2  1.6 0.6  1.3 0.4  1.2 1.1  1.3 0.8  1.4 1.4  1.2a 0.9  1.2 1.6  1.1a
SF (%) 36.0  6.0 34.2  6.0 34.7  4.2 37.0  5.5 32.4  4.2 32.9  13.5 36.6  8.3 24.1  14.9 37.3  5.5 15.1  11.5a
SFmw (%) 19.5  3.1 21.1  5.1 19.5  3.8 18.0  4.2 15.8  3.2 14.8  6.4 21.1  5.0 11.8  7.7a 20.9  4.3 8.6  6.8a
VCFc (circ/sec) 1.8  0.4 1.6  0.4 1.7  0.3 1.8  0.5 1.6  0.2 1.6  0.7 1.8  0.5 1.1  0.7 1.8  0.3 0.7  0.5
VCFcmw (circ/sec) 1.0  0.2 1.0  0.3 1.0  0.2 0.9  0.2 0.8  0.2 0.7  0.3 1.1  0.3 0.5  0.3 1.0  0.2 0.4  0.2
Heart rate (beats/min) 284  32 292  37 309  47 299  42 310  25 305  37 281  42 306  42 286  31 293  33
SBP (mm Hg) 80  19 98.3  22.5 83  30 89.8  17.5 83  13 108.5  14.5 89  13 107.7  26 87  11 107  24.7
LVEDD (cm) 0.8  0.1 0.79  0.12 0.9  0.1 0.84  0.13 1.0  0.1 1.03  0.31 1.0  0.2 1.28  0.42 1.0  0.2 1.57  0.57a
Body weight (kg) 0.35  0.28 0.34  0.05 0.54  0.46 0.61  0.08 0.86  0.20 0.81  0.12 1.33  0.24 1.15  0.22 1.59  0.48 1.34  0.38
LV, Left ventricular; SF, shortening fraction; SFmw, midwall shortening fraction; VCFc, rate of circumferential fiber shortening; VCFcmw, midwall equivalent of rate of circumfer-
ential fiber shortening; SSI, stress shortening index; SSImw, midwall equivalent of stress shortening index; SVI, stress velocity index; SVImw, midwall equivalent of stress velocity
index; SBP, systolic blood pressure; LVEDD, left ventricular end-diastolic dimension. aP< .05 compared with age-matched sham operated controls by Kruskal–Wallis (Z-scores
and SF) or analysis of variance (SF, VCFc, SBP, LVEDD). Echocardiographic indices in normal sham-operated rabbits measured at 3 to 7 weeks of age. Data are mean standard
deviation, n ¼ 13 each.at 7 weeks of age was 22%  5% greater than at 3 weeks
(P< .05). Compared with age-matched sham-operated ani-
mals at 7 weeks of age, total LV myocyte number decreased
by 18% 4% (P<.05), and myocyte volume increased an
additional 43%  8% (P< .05) in banded animals.
The relative proportion of collagen and muscle tissue n
LV myocardium was assessed by Masson’s trichrome stain-
ing. Collagen represented approximately 6%  2% of LV
myocardial area. This was not changed with increasing
age. There was also no significant difference between late
hypertrophy (7 weeks) and age-matched controls in the
LV area taken up by collagen (P> .1).
DISCUSSION
Improved surgical techniques and younger age of repair
have improved outcome in congenital heart disease. Despiteadvances in operative techniques and myocardial preserva-
tion methods, progressive ventricular dysfunction remains
one of the most important problems that hamper long-term
outcome in the treatment of congenital heart disease. A
growing body of evidence indicates that apoptosis is respon-
sible for some degree of myocyte loss and myocardial dys-
function resulting from hypoxia, ischemia, reperfusion,
hypertrophy, heart failure, and inflammation.9-14,16,18 The
major findings in the present study in the developing, pres-
sure-loaded left ventricle are that significant myocyte apo-
ptosis 1) begins with the onset of abnormal loading, 2) is
not attenuated by normalization of wall stress during the
period of compensatory hypertrophy, and 3) is sufficient to
result in a measurable decrease in cardiomyocyte number
as the ventricular dysfunction progresses to failure.
Chronic pressure overload-induced failure of the adult
heart has long been suspected to be related to exacerbatedFIGURE 1. Effects of aortic banding of infant rabbits on LVmass:volume
ratio determined by serial echocardiography. Data are mean  standard
deviation (SD), n ¼ 6–10 each. #P< .05 versus age-matched controls.
*P< .05 versus 4-week-old banded. LV mass:volume ratio increases early
in hypertrophy and then progressively declines. LV, Left ventricular.
FIGURE 2. Effects of aortic banding of infant rabbits on LV peak systolic
stress. Data are mean  SD, n ¼ 6–10 each. Peak systolic stress is reduced
in banded animals at 4 weeks in association with increased LV mass (see
Figure 1). Failure of continued hypertrophy in the face of increasing after-
load results in a progressive increase in peak systolic stress. *P<.05 versus
controls. PkSS, Peak systolic stress.
The Journal of Thoracic and Cardiovascular Surgery c Volume 137, Number 6 1359
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DFIGURE 3. Apoptosis in LV myocardium of control sham-operated and banded infant rabbits. A, Representative fluorescent photomicrographs of 5-mm
sections of the LV wall from banded rabbits. Sections were labeled with Hoechst to stain nuclear DNA (blue), desmin to identify cardiomyocytes (red),
and DNA strand breaks (TUNEL-green). After image acquisition, images were subjected to 2-dimensional ‘‘no neighbors’’ deconvolution using a kernel
that estimates the 3-dimensional point spread function based on the optics and imaging system. A and B, Banded animal at 3 weeks. C and D, Banded animal
at 7 weeks. Apoptotic nuclei localized to myocytes (arrows); TUNEL-positive staining in non-myocytes (asterisks). B, Assessment of myocyte apoptosis in
sham versus banded animals using this approach. Data are mean  SD, n ¼ 6–8 each. The difference between sham-operated and banded animals was sig-
nificant at all ages.cardiomyocyte apoptosis.23 This link has been demonstrated
in several experimental models,21,22 and mitochondrial
proteins (eg, apoptosis-inducing factor) and myogenic tran-
scriptional regulators (eg, MyoD) have been recently impli-
cated in the molecular mechanism.24,25 However, neither the
time course nor the interrelation of cardiomyocyte apoptosis
with the intricate changes in in vivo myocardial mechanics
in response to pressure overload has been systematically
analyzed. Moreover, the developing infant heart is likely
to respond to pressure overload in a manner that is funda-
mentally different from the one observed in adult myocar-
dium. The amount of myocyte apoptosis found in the1360 The Journal of Thoracic and Cardiovascular Spresent study is quantitatively similar to that measured
in adult studies of pacing-induced heart failure, diabetes,
and ischemic cardiomyopathy.14,17 However, the degree to
which apoptotic myocyte loss contributes to myocardial
dysfunction and pathologic remodeling in any of these states
remains uncertain. The effects of myocyte loss on ventricu-
lar function in the growing ventricle are likely to be at least
as great as in the adult because of the significant increases in
cardiac size and function that must occur to permit body
growth. The physiologic remodeling and hypertrophy that
accompany normal growth require maintaining an adequate
number of myocytes, which are generally believed to beurgery c June 2009
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Dterminally differentiated and thus incapable of significant
replacement. However, given the recent appreciation of
the potential for cardiomyocyte regeneration by cell cycle
reentry or via resident myocardial precursor cells, studies
of myocyte proliferation as a possible mechanism to com-
pensate for the hypertrophy-induced cell loss are clearly
warranted.
The sensing and transduction mechanisms by which
abnormal load is perceived and leads to the hypertrophic re-
sponse remain uncertain, as are specific mechanisms respon-
sible for myocyte apoptosis during hypertrophy. Current
work favors connections between the myocyte cytoskeleton
and the extracellular matrix, most likely focal adhesion
kinases and integrins; signaling protein kinases within the
extracellular matrix, altered sarcomeric function, altered
substrate metabolism, ionic fluxes, and local neurohumoral
mechanisms may also be involved in initiating the hypertro-
phic response.2 Downstream from the initiating signals,
local production of cytokines, growth factors, catechol-
amines, and other compounds (eg, endothelin, angiotensin)
stimulate myriad protein kinases and phosphatases, thereby
promoting numerous quantitative and qualitative changes in
gene expression. In many ways these responses recapitulate
the fetal cardiomyocyte gene program and result in substan-
tial alterations in cardiomyocyte signaling and functional
pathways.2-6 The molecular events occurring during the hy-
pertrophic response that could alter cell survival are numer-
ous and include imbalances in cell survival and death
pathways, such as those related to G-protein signaling, tu-
mor necrosis factor-a, phosphoinositide 3-kinase, calci-
neurin, and gp130, as well as altered calcium homeostasis,
mitochondrial and substrate metabolism, and ischemia
caused by insufficient capillary development. We found
that apoptotic cell death is initiated during early compensa-
tory hypertrophy and ultimately leads to a net loss of approx-
imately 18% of the myocytes in our rabbit model.
FIGURE 4. LVmyocardial caspase-3 activity measured by cleavage of the
specific fluorescent substrate DEVD-AFC (BioMol, Plymouth Meeting, Pa)
in age-matched sham operated control (open bars) and banded hypertrophy-
ing (solid bars) hearts. Data are mean  SD, n ¼ 5–7 per group and ex-
pressed as arbitrary fluorescent units relative to that measured in 7-week
controls. *P ¼ .04. #P ¼ .03.þP ¼ .008.The Journal of Thoracic and CIn adult models, a low but significant frequency of cardi-
omyocyte apoptosis has been found in experimental hyper-
tension and during the transition to failure (but not during
adaptive compensation) in experimental aortic stenosis, pac-
ing-induced heart failure, and humans with dilated cardio-
myopathy and diabetes.10,14,16-18,22 In the present report,
the presence of both cardiomyocyte-specific TUNEL stain-
ing and LV tissue caspase-3 activity represent relatively
strong evidence that 1 or more proapoptotic programs are
activated early in infant LV as it is responding to increased
pressure loading. It is important to note that both results,
although significant, are relatively modest in absolute quan-
titative terms compared with what has been reported in
a variety of ischemia-reperfusion and other models. For ex-
ample, 8-week-old rabbit left ventricles subjected to 20 min-
utes of normothermic ischemia followed by 2 hours of
reperfusion demonstrated an approximate 7- to 12-fold in-
crease in caspase-3 activity (data not shown). In addition,
these indices represent but a snapshot in time of a process
that most likely is continuing and evolving over many
days to weeks. Clearly, it would be useful to try to establish
the quantitative relationship between the rate of apoptosis
and the magnitude of ultimate cell loss. This computation,
however, requires knowledge of the duration of TUNEL
or other apoptotic signals in a cell that undergoes pro-
grammed cell death, which is not known and currently diffi-
cult or impossible to measure in in vivo models. However,
there is increasing evidence that a relatively modest degree
of apparent cardiomyocyte apoptosis similar to that ob-
served in the present study can have progressive and delete-
rious contractile consequences over time.22,26 One recent
study in sheep subjected to LV pressure overload also dem-
onstrated onset of caspase activation during the apparent
‘‘compensated’’ phase of LV hypertrophy, which markedly
increased during the development of LV failure.22 In terms
of evolving contractile dysfunction, it is also important to
note that caspase activation in cardiomyocytes can poten-
tially result in the cleavage of contractile proteins (and
thus contribute to the development of contractile dysfunc-
tion) independently of or in conjunction with effects leading
to cell death.27
The present study is the first to identify an increase in ap-
optotic cardiomyocytes during the early phase of adaptive
hypertrophy. This is an important finding because it suggests
that normalizing wall stress in the absence of other interven-
tions is not sufficient to attenuate proapoptotic signals active
in pressure-loaded myocardium. This result is consistent
with recent evidence that normalizing wall stress is not es-
sential to preserve contractile function and prevent ventricu-
lar dilatation in chronic pressure overload.6,28
Study Limitations
There are several important limitations to the present
study: TUNEL staining has well-known difficulties,ardiovascular Surgery c Volume 137, Number 6 1361
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scopic method used did identify apoptotic myocytes with
known sensitivity and specificity that have been used and
validated under similar circumstances by others.14,16,17
TUNEL and other methods that detect DNA damage can
show false-positive results, particularly in settings of necro-
sis (eg, ischemia); however, the occurrence of ischemia and
necrosis would seem to be unlikely in early and compensated
stages of hypertrophy.Moreover, wewere able to support the
likelihood of increased apoptotic events using a sensitive and
specific fluorescent substrate for caspase-3; unfortunately,
when this assay is performed on whole LV tissue it cannot
reveal the cell type(s) responsible for any measured increase
in caspase activity. However, these results, when taken
together with the subsequent measured decrease in myocyte
number, strongly support the conclusion that substantial
cardiomyocyte apoptosis was occurring in this model.
As noted above, the pathways involved in hypertrophy-
associated programmed cell death are likely to be multiple
and interwoven. A related issue that must be addressed in
the future is whether the observed frequency of myocyte ap-
optosis and reduced number of cardiomyocytes are impor-
tant causes of the progression to failure that should be
targeted for inhibition or instead is facilitating the controlled
and beneficial (as opposed to necrosis, cell lysis, and inflam-
mation) removal of damaged and dysfunctional myocytes
and is therefore protective. It should also be emphasized
that our findings cannot be directly translated to the setting
of pressure-overload hypertrophy in the adult heart. In our
model, the animal slowly grows into the aortic band, devel-
oping progressive constriction. These kinetics cannot be
mimicked in adult rabbits. Similarly, the situation in mani-
fest end-stage heart failure is probably different from that
during compensated hypertrophy, but this was not a focus
of the present study.
CONCLUSIONS
This study indicated that myocyte apoptosis is induced by
pressure overload in the infant myocardium and is not atten-
uated during the period of compensated hypertrophy and
normalized wall stress. From a clinical standpoint, these
data suggest the pressure load, even at its earliest stages, is
not tolerated by the developing left ventricle. They therefore
support early and complete hemodynamic correction in the
infant whenever possible.
References
1. Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in
the human left ventricle. J Clin Invest. 1975;56:56-64.
2. Lorell BH, Carabello BA. Left ventricular hypertrophy: pathogenesis, detection,
and prognosis. Circulation. 2000;102:470-9.
3. MacLellan WR, Schneider MD. Genetic dissection of cardiac growth control
pathways. Annu Rev Physiol. 2000;62:289-319.
4. Molkentin JD, Dorn IG 2nd. Cytoplasmic signaling pathways that regulate car-
diac hypertrophy. Annu Rev Physiol. 2001;63:391-426.1362 The Journal of Thoracic and Cardiovascular Su5. Sadoshima J, Izumo S. The cellular and molecular response of cardiac myocytes
to mechanical stress. Annu Rev Physiol. 1997;59:551-71.
6. Sano M, Schneider MD. Still stressed out but doing fine: normalization of wall
stress is superfluous to maintaining cardiac function in chronic pressure overload.
Circulation. 2002;105:8-10.
7. Tamai J, Hori M, Kagiya T, Iwakura K, Iwai K, Kitabatake A, et al. Role of alpha
1-adrenoceptor activity in progression of cardiac hypertrophy in guinea pig hearts
with pressure overload. Cardiovasc Res. 1989;23:315-22.
8. Teiger E, Than VD, Richard L, Wisnewsky C, Tea BS, Gaboury L, et al. Apopto-
sis in pressure overload-induced heart hypertrophy in the rat. J Clin Invest. 1996;
97:2891-7.
9. Anversa P, Olivetti G, Leri A, Liu Y, Kajstura J. Myocyte cell death and ventric-
ular remodeling. Curr Opin Nephrol Hypertens. 1997;6:169-76.
10. Ding B, Price RL, Goldsmith EC, Borg TK, Yan X, Douglas PS, et al. Left ven-
tricular hypertrophy in ascending aortic stenosis mice: anoikis and the progression
to early failure. Circulation. 2000;101:2854-62.
11. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL. Reperfusion
injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest. 1994;94:
1621-8.
12. Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, et al.
Apoptotic and necrotic myocyte cell deaths are independent contributing variables
of infarct size in rats. Lab Invest. 1996;74:86-107.
13. Kajstura J, Cheng W, Sarangarajan R, Li P, Li B, Nitahara JA, et al. Necrotic and
apoptotic myocyte cell death in the aging heart of Fischer 344 rats. Am J Physiol.
1996;271(3 Pt 2):H1215-28.
14. Kajstura J, Zhang X, Liu Y, Szoke E, ChengW, Olivetti G, et al. The cellular basis
of pacing-induced dilated cardiomyopathy. Myocyte cell loss and myocyte cellu-
lar reactive hypertrophy. Circulation. 1995;92:2306-17.
15. Kumar D, Kirshenbaum L, Li T, Danelisen I, Singal P. Apoptosis in isolated
adult cardiomyocytes exposed to adriamycin. Ann N Y Acad Sci. 1999;874:
156-68.
16. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, et al. Ap-
optosis in myocytes in end-stage heart failure. N Engl J Med. 1996;335:1182-9.
17. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, et al. Apoptosis
in the failing human heart. N Engl J Med. 1997;336:1131-41.
18. Olivetti G, Quaini F, Sala R, Lagrasta C, Corradi D, Bonacina E, et al. Acute myo-
cardial infarction in humans is associated with activation of programmed myocyte
cell death in the surviving portion of the heart. J Mol Cell Cardiol. 1996;28:
2005-16.
19. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science.
1995;267:1456-62.
20. Condorelli G, Morisco C, Stassi G, Notte A, Farina F, Sgaramella G, et al. In-
creased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic
genes bax and bcl-2 during left ventricular adaptations to chronic pressure over-
load in the rat. Circulation. 1999;99:3071-8.
21. Li Z, Bing OH, Long X, Robinson KG, Lakatta EG. Increased cardiomyocyte
apoptosis during the transition to heart failure in the spontaneously hypertensive
rat. Am J Physiol. 1997;272(5 Pt 2):H2313-9.
22. Moorjani N, Ahmad M, Catarino P, Brittin R, Trabzuni D, Al-Mohanna F, et al.
Activation of apoptotic caspase cascade during the transition to pressure overload-
induced heart failure. J Am Coll Cardiol. 2006;48:1451-8.
23. Bing OH. Hypothesis: apoptosis may be a mechanism for the transition to
heart failure with chronic pressure overload. J Mol Cell Cardiol. 1994;26:
943-8.
24. Ha T, Hua F, Li Y, Ma J, Gao X, Kelley J, et al. Blockade of MyD88 attenuates
cardiac hypertrophy and decreases cardiac myocyte apoptosis in pressure over-
load induced cardiac hypertrophy in vivo. Am J Physiol Heart Circ Physiol.
2006;290:H985-94. Epub 2005 Sep 30.
25. van Empel VP, Bertrand AT, van der Nagel R, Kostin S, Doevendans PA,
Crijns HJ, et al. Downregulation of apoptosis-inducing factor in harlequin mutant
mice sensitizes the myocardium to oxidative stress-related cell death and pressure
overload-induced decompensation. Circ Res. 2005;96:e92-101.
26. Foo RS, Mani K, Kitsis RN. Death begets failure in the heart. J Clin Invest. 2005;
115:565-71.
27. Communal C, Sumandea M, de Tombe P, Narula J, Solaro RJ, Hajjar RJ. Func-
tional consequences of caspase activation in cardiac myocytes. Proc Natl Acad Sci
U S A. 2002;99:6252-6.
28. Esposito G, Rapacciuolo A, Naga Prasad SV, Takaoka H, Thomas SA, Koch WJ,
et al. Genetic alterations that inhibit in vivo pressure-overload hypertrophy pre-
vent cardiac dysfunction despite increased wall stress. Circulation. 2002;105:
85-92.rgery c June 2009
Choi et al Congenital Heart Disease
The JournAppendix. Echocardiographic methodsC
H
DBlood Pressure
Determination of the accuracy of optical plethysmogra-
phy was performed on 8 occasions in rabbits aged 4 to
6 weeks. After anesthesia was induced with intramuscular
ketamine (20 mg/kg) and xylazine (0.5 mg/kg), the right
upper limb was shaved and topical alcohol was applied.
Dissection of the neck vessels and direct cannulation of
the carotid artery were achieved using a 24-gauge poly-
ethylene catheter. A 2F high-fidelity (Millar, Houston,
Tex) catheter was inserted in line with the fluid-filled
catheter. The central arterial waveform was captured dig-
itally using a standard analog-to-digital converter at a
sampling rate of 200 Hz. Simultaneous right upper limb
brachial arterial blood pressure was determined using op-
tical plethysmography (Finapress, Ohmeda, Englewood,
Colo). The Finapress was applied to the shaved right fore-
arm after application of topical alcohol over the region of
the palpable brachial artery.
Comparison of the noninvasive arterial waveform with the
high-fidelity direct central measurement was performed using
customized software. Beat-to-beat waveform segmentation
was followed by peak and trough detection to calculate sys-
tolic and diastolic values. Determination of the variation
(bias) of optical plethysmography compared with Millar mea-
surement was expressed as the mean and standard deviation
(SD) of the difference between noninvasive and invasive
values. To estimate the magnitude of error (accuracy) the
mean  SD of the absolute differences was calculated. To
quantify the magnitude of error in relationship to derived vari-
ables of stress, a comparison of Finapress-derived versus
Millar-derived ESS and peak systolic stress was also per-
formed. The bias, accuracy, and mean percentage absolute
error were then calculated.
Spectral analysis of power and frequency components
was performed on both the noninvasive and invasive arterial
waveforms. Spectral analysis was performed using a non-
parametric spectral estimation technique based on a discrete
Fourier transform. Specifically, a modified averaged perio-
dogram method was used to decrease the high variance
incurred with direct application of the discrete Fourier trans-
form. A 30-second data segment was used for power spectral
analysis. Transfer function (magnitude and phase) and
power spectrum were assessed.
A comparison of the direct high-fidelity central arterial sys-
tolic and diastolic blood pressure and those recorded by Fina-
press was determined. The noninvasive waveform revealed
a narrower pulse pressure andgenerally higher diastolic blood
pressure.Bias asmeasured bymean and1SD for the errorwas
1.1  4.0 and 0.85  3.2 mm Hg for systolic and diastolic
blood pressures, respectively. Accuracy, the absolute mean,
and SD of the error was 5.9  4.7 and 9.2  6.9 mm Hg for
systolic and diastolic blood pressures, respectively.al of Thoracic and CarFourier analysis revealed similar frequency components
for both Millar and Finapress waveforms. A similar time
course of the pressure waveforms was documented, sup-
ported by the transfer magnitude approximating one. Nonin-
vasive waveform contains less power at the beat frequency
and its harmonics, suggesting that it does underestimate
the pulse pressure. A phase lag consistent with the more
peripheral measurement of the Finapress was noted.
To better appreciate the error incurred using the Finapress
blood pressure in the determination of derived stress indices,
calculation of derived myocardial indices at the time of inva-
sive versus noninvasive blood pressure comparison was per-
formed. The noninvasively derived indices were compared
with invasively derived indices using the same measures
of chamber size and wall thickness. Overall, there was
a small underrepresentation of both stress measures (end
systolic and peak systolic). Bias was4.6  8.8 and10.5
 16.3 g/m2 and accuracy was 6.95  7.1 and 14.1 
13.2 g/m2 for end-systolic and peak systolic stress, respec-
tively. The mean percentage absolute error was 11.0 
7.4% for ESS and 8.15  4.9% for peak systolic stress.
Echocardiography
Weekly assessment of cardiac functionwas performed from
the time of aortic banding.Noninvasive blood pressure assess-
ment was limited by animal size and first measured at 3 weeks
of age. All earlier studies were limited to 2-dimensional and
M-mode echocardiographic assessment. Thereafter, weekly
evaluations were performed using echocardiographic and op-
tical plethysmography. Transthoracic echocardiography was
performed using an Acuson 128 (Siemens USA, Malvern,
Pa) or Hewlett-Packard Sonos 1500 Cardiac Imager (Philips
Healthcare, Andover, Mass) equipped with a 7 to 7.5-MHz
transducer. Adequate ultrasound surface-interface coupling
was achieved by initial shaving of the anterior surface of the
thorax and application of ultrasound gel. All imagingwas per-
formed under light restraint without sedation. Pulsed Doppler
interrogation of the LV outflow tract from an apical viewwith
simultaneous electrocardiogram was recorded at high-speed
(100 mm/s), hard-copy printout from the strip chart recorder
for determination of ejection time. Two-dimensional cross-
sectional imaging and M-mode interrogation of the LV short
axis at the level of the papillary muscles were performed.
High-speed (100 mm/s), hard-copy, 2-dimensionally directed
echocardiographic M-mode recordings of the LV minor axis
were recorded simultaneously with electrocardiogram and
noninvasive peripheral arterial pulse waveform using optical
plethysmography (Finapress).
Determination of the normal endocardial SSI and SVI re-
lationships and their midwall equivalents (SSImw SVImw)
was undertaken in 13 control animals between weeks 3
and 7. To determine the normal relationship of the functiondiovascular Surgery c Volume 137, Number 6 1362.e1
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Dindices to afterload, assessment at resting afterload was fol-
lowed by determination at increased afterload during atro-
pine and methoxamine administration. The animals were
premedicated with atropine, 0.01 mg/kg (minimum dose of
0.1 mg) intravenously, to maintain a stable heart rate during
subsequent studies with repeat dosing as needed. After sev-
eral stable recordings to determine baseline blood pressure
and afterload, an intravenous infusion of methoxamine (25
mg/kg/min) was begun. A gradual increase in systolic blood
pressure to 36 to 60 mm Hg above baseline was obtained. A
total of 56 measurements were obtained.
Analysis of Echocardiography
The noninvasive arterial pulse tracing, LV endocardial bor-
der of the septum, and endocardial and epicardial borders of
the posteriorwallwere handdigitized using abit pad interfaced
to a microcomputer-based digitizing station with custom soft-
ware. This system is programmed to adjust the sampling rate of
the tablet to 200 Hz, which is adequate to obtain 20 to 25 non-
aliased harmonics of heart rates of 240 to 300 beats/min. After
data input, the pulse transmission delay is corrected by elec-
tronically aligning the pulse upstroke to the time of the onset
of ejection as determined from the LV outflow Doppler
sample. End systole was defined as the time of cessation of
antegrade flow as determined from the LV outflow track
Doppler signal. The time of end systole was used to ascertain
end-systolic pressure from the blood pressure recording.
From the digitized data, the following measurements were
obtained by averaging 3 cardiac cycles: 1) pressure during
LV ejection, calculated by assignment of diastolic pressure
to the minimum and systolic pressure to the maximum of
the pulse tracing; 2) LV internal diameter; 3) LV posterior
wall thickness; 4) LV midwall dimensions by the method
of Shimizu and colleagues; 5) LV meridional wall stress in
grams/centimeters squared, calculated throughout ejection
according to Grossman and colleagues:1




where P is the LV pressure in millimeters of mercury, D is the
LV endocardial cross-sectional diameter in centimeters, h is
the posterior wall thickness in centimeters, and 1.35 is the
conversion factor frommmHg to grams/centimeters squared,





From the continuous data, end-diastolic values for short-
axis dimension and wall thickness were taken at the time of
maximal LV dimension, and end-systolic values for short-
axis dimension, wall thickness, blood pressure, meridional
wall stress, and FSwere determined at the time of end systole1362.e2 The Journal of Thoracic and Cardiovascularon the Doppler tracing. Meridional peak systolic stress and
FS were obtained from the continuous systolic stress cal-
cultation. Similar calculations were performed for peak and
end-systolic FS. LV ejection time was measured from the
LV outflow Doppler tracing and adjusted to the heart rate
of 60 beats/min by dividing by the square root of the R-R in-
terval on the electrocardiogram. TheLVcircumferential fiber
SF and midwall SFwere calculated with the use of short-axis
dimensions as (end-diastolic dimension – end-systolic di-
mension)/end-diastolic dimension. VCFc was calculated as
the SF divided by the rate-adjusted ejection time. Midwall
VCFc was similarly calculated using midwall equivalents.
The LV mass:volume ratio was estimated from determina-
tion of LV epicardial and endocardial cross-sectional area
as determined from M-mode measurements.
Stress-velocity and Stress-shortening Indices
The relation between rate-adjustedmean velocity of short-
ening and end-systolic meridional stress (SVI) has been
shown to be an afterload-adjusted, preload-independent in-
dex of contractility whether obtained as a global or regional
index. The relation is inversely linear, and in healthy humans
the slope of the relationship for any one person is parallel to
the slope of the relation for the total study group. The value
of the SVI for each banded rabbit was determined relative
to the calculated distribution of this index in normal subjects.
The SVI is reported as a normal deviate (Z-score) relative to
the distribution in normal subjects. Thus, the SVI¼ (X1-m)/s
whereX1¼measured rate-adjustedmean velocity of circum-
ferential fiber shortening, m ¼ the group mean rate-adjusted
mean velocity of circumferential fiber shortening for the
measured end-systolic meridional stress, and s ¼ the stan-
dard error of the regression for the group stress-velocity in-
dex at that level of end-systolic meridional stress. An SVI
of less than negative 2 (ie, 2 SD below the normal mean
value) was considered to represent myocardial dysfunction.
Similarly, the SSI is the relation of SF and ESS. This index
of contractility is preload sensitive. The SSI is correspond-
ingly quantified as the normal deviate of SF for the given
ESS, obtained in a manner analogous to that described for
the SVI. FS is stress independent of radial forces and was
used relative to midwall cardiac performance measures
(SFmw andVCFmw) to determine load-independent measures
of contractility (SSImw and SVImw).
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